Infantile myofibromatosis: First drug targets in childhood genetic tumor disorder
Friday, May 24, 2013 - 10:01
in Biology & Nature
Two mutations central to the development of infantile myofibromatosis (IM) -- a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers.